CONNECT WITH US:
Jun 23, 2022 09:00 JST
Source: Novotech Health Holdings Pte Ltd
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
CHICAGO, IL, Jun 23, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).
Novotech CEO Dr. John Moller said the company was extremely pleased to receive this award for the second consecutive year. "Receiving this recognition from our clients is incredibly important to us and is an endorsement of our service delivery model that is tailored to the needs of biotech clients. Our local teams have exceptional site and investigator access, our project management approach emphasises problem-solving, ownership and flexibility, and our investments in data and technology ensure clients have real-time access to the trial performance."
Book a meeting with one of the Novotech experts at DIA here.
Clinical Leader and Life Science Leader working with Industry Standard Research (ISR), selected Novotech for the CRO Leadership Award.
According to the CRO Leadership Award research team: "The awards are based on customer feedback. Winning CROs are chosen through impartial market research based on feedback from sponsor companies that utilize outsourcing services. Primary market research by ISR Reports is the basis of the awards. Sponsors provide ratings of CROs based on recent outsourced projects. This experiential feedback is analyzed by sponsor company size to reveal leading CROs in different performance categories."
Ed Miseta, Chief Editor for Clinical Leader said: "Selecting the right CRO can make or break your project. It can lead to a successful regulatory submission and approval or cost you a lot of time and effort on a failed study. That makes CRO selection a stressful decision for any clinical operations manager. Regardless of whether you are concerned about compatibility, capabilities, expertise, quality, or reliability. We believe our CRO Leadership Awards will help managers with their search process and hopefully help to connect them with the right contract partner. We are grateful to our colleagues at ISR Reports for conducting the research necessary to produce these awards. These award winners have proven themselves to be the top service providers in each category. I congratulate all of them for the work ethic they exhibit in consistently meeting the needs of their drug development clients."
Kevin Olson, CEO of Industry Standard Research said: "Industry Standard Research (IRS) continues to consider it an honor to provide the primary market research data for Life Science Leader and Clinical Leader's CRO Leadership Awards. ISR's stringent screening process ensures that only highly qualified industry decision-makers participate in our CRO benchmarking market research. This is paramount as we ask the research participants to provide experiential, not perceptual, feedback on their involvement with contract suppliers over the past 18 months. The data enable users of ISR's market research to make confident business decisions based on the experiences of their industry peers."
Novotech, which has a reputation for delivering full-service, high-quality expedited clinical trials in Asia-Pacific, can now offer its biotech clients clinical services in the US to support later phase global studies. Novotech now has a workforce of ~2,500 clinical trial professionals across Australia, South Korea, Greater China, Southeast Asia, India, South Africa and the US.
Novotech CEO Dr. John Moller said Novotech's Asia-Pacific and US teams support cost-effective expedited clinical research with world-class data and the most advanced technology including solutions that enable acceleration of clinical trials across the regions. "The focus on Asia-Pacific for biotech clinical research over the past five years makes the region the fastest-growing clinical trial destination with China being the leading location for new trials followed by the US. Asia-Pacific offers a compelling solution for expedited clinical trials especially in oncology with its vast patient populations, less competitive clinical trial landscape, and world-class KOLs, in addition regulatory reforms, such as those in China, have accelerated approval processes. The expansion into the US was a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in APAC and the US, and for our APAC clients wanting US clinical programs."
About Novotech Health Holdings Pte Ltd ("Novotech")
Novotech is the leading Asia-Pacific and US biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427
Sectors: BioTech, Healthcare & Pharm, Clinical Trials
Copyright ©2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Fujitsu Spain receives 9th award of the "Fundación Consejo España-Japón" (Spain-Japan Foundation)
Oct 05, 2022 14:13 JST
Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan
Oct 04, 2022 16:44 JST
MHI Group Delivers Two Large-Capacity Centrifugal Chillers for Singapore's Marina Bay District Cooling System
Oct 04, 2022 11:58 JST
Rinnai and Toyota Start Exploring Hydrogen-Powered Cooking Methods
Oct 04, 2022 11:02 JST
Neste, Idemitsu Kosan, CHIMEI and Mitsubishi Corporation join forces to create a renewable plastics supply chain
Oct 03, 2022 17:11 JST
Rovanpera crowned youngest ever champion with TOYOTA GAZOO Racing
Oct 03, 2022 11:15 JST
Hitachi Astemo develops Steer-by-Wire prototype with advanced steering and failsafe function
Oct 03, 2022 09:30 JST
NEC Announces Progress on Environmental, Social and governance initiatives to support sustainable growth for the company and society
Sep 30, 2022 14:48 JST
Fujitsu highlights technologies to realize its vision for a sustainable world at CEATEC 2022
Sep 30, 2022 11:43 JST
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Sep 30, 2022 11:00 JST
Dell Technologies and Fujitsu Collaborate to Accelerate Open RAN Global Adoption
Sep 30, 2022 10:41 JST
MHI: Advanced light water reactor "SRZ-1200"
Sep 29, 2022 17:55 JST
AEON and CJPT Begin Logistics Improvement in Kyushu
Sep 29, 2022 17:20 JST
NTT DOCOMO and NEC Reduce Power Consumption for 5G SA Core by an Average of 72% using AWS Graviton2, Followed by a Successful Onboarding of 5G SA Core on Hybrid Cloud
Sep 29, 2022 16:50 JST
NEC and Red Hat Expand Global Collaboration to Drive IT Modernization and Digital Transformation
Sep 29, 2022 16:23 JST
NTT DOCOMO to Add Fourth Virtualized Base Station to Open RAN Verification Environment
Sep 29, 2022 11:16 JST
NEC Launches Open RAN cloud-native virtualized software suite to extend the NEC Open Networks best of breed ecosystem
Sep 29, 2022 09:11 JST
MHI and Institut Teknologi Bandung Launch Joint R&D for Ammonia-Fired Power Generation Using Gas Turbines in Indonesia
Sep 28, 2022 16:05 JST
Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint
Sep 28, 2022 15:15 JST
NEC Launches North American Innovation Hub for Open RAN
Sep 28, 2022 14:50 JST
More Latest Release >>
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference
September 15 2022 17:00 JST
Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC
September 05 2022 18:00 JST
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
September 02 2022 14:00 JST
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"
July 25 2022 09:00 JST
Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T"
July 18 2022 16:00 JST
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
July 13 2022 14:30 JST
Novotech Receives "Best Biologics CRO Award 2022" at Korea Bioprocessing Excellence Awards 2022
June 29 2022 07:00 JST
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
June 15 2022 08:30 JST
Novotech's APAC and USA Leadership Teams at BIO 2022
June 14 2022 22:00 JST
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
June 06 2022 18:00 JST
More Press release >>